Early Access News Search Results

Get the latest updates from Early Access Care at the 2025 ASCO Annual Meeting, showcasing innovations in oncology access and investigational medicine pathways.

Explore key takeaways from the 2025 Operationalize Expanded Access Programs Summit, where Early Access Care shared insights on improving patient pathways.

Early Access Care focuses on supporting caregivers and families by working with patients and advocates to develop programs for access to investigational medicines. Join us at the Europe EAP Summit on October 8, 2024, in London to hear a family’s inspiring 5-year journey.

Join us at the 3rd Operationalize Expanded Access Programmes Summit Europe, 7-9 Oct 2024, at Millennium Gloucester Hotel, London. Learn about program setup, regulatory pathways, data collection, real-world data, exit strategies, and patient support.

EARLY ACCESS CARE IS AN EXHIBITING SPONSOR OF ASCO IN 2024

Early Access Care will be participating at the Operationalize Expanded Access Programs on March 19 - 21, 2024 in Boston, MA. Join colleagues across the pharmaceutical industry as they come together to share ideas and learn about Expanded Access, Compassionate Use, and Post Trial Access programs.

The ESMO Annual Meeting 2023 Congress (Madrid, 20-24 October) is now over, and we summarized lessons learned for compassionate use and expanded access programs – enabling new and familiar science into compassionate use programs...

Early Access Care – Innovation in pre-approval access. We’re leading the path forward...

Early Access Care is excited to annouce the upgrade of the earlyaccesscare.com Website! We have expanded our features to include Frequently Asked Questions as well as Glossary Terms. Take a loook around!

We look forward to speaking with attendees at ASCO '23 about Expanded Access Program options. Visit at Booth 11091!

There has been a global increase in the use of smart phones and wearables such as FitBits and Apple Watches. Online visits with medical providers and e-portals such as MyChart have become common place. There are many applications available that continuously and effortlessly capture data to aid in...

Learn how the FDA’s latest statement on open-label extensions (OLE) impacts post-trial access and Early Access Care's approach to continued treatment.

Gain a clear understanding of expanded access programs and how Early Access Care helps patients obtain investigational treatments when no other options remain.

Early Access Care proudly celebrates its fifth year as a sponsor at ASCO, reaffirming its commitment to advancing access in oncology research.

Learn about the critical role of compassionate use and expanded access programs in delivering hope to patients with no other treatment options.

Recap Early Access Care’s 2022 conference presence, featuring expert panels and thought leadership on compassionate use and expanded access programs.

Explore the growing role of real-world data in expanded access protocols and how Early Access Care helps sponsors integrate evidence effectively.

Examine the FDA’s position on post-trial treatment and the ethical responsibilities of sponsors, as explained by Early Access Care.

Identify and manage scope creep risks in expanded access programs with expert guidance from Early Access Care to protect compliance and program success.

Discover how Early Access Care participated in key 2021 conferences, advancing global conversations on access to investigational treatments and rare disease care.

See how Early Access Care drives global progress in early access through strategic partnerships that expand availability of investigational therapies.

Discover how Early Access Care is enhancing data integrity and efficiency through its agreement with Veeva Systems for clinical data management.

Learn about FDA’s Project Facilitate and how Early Access Care collaborates with regulators to simplify oncology-related expanded access requests.

Discover the anticipated launch of FDA’s Project Facilitate and how it’s designed to support physicians navigating oncology expanded access applications.

Review the FDA's official stance on post-trial access and how Early Access Care ensures ethical continuation of care for trial participants in need.

A detailed report on how real-world treatment experience from expanded access can inform regulatory, clinical, and access decisions.

Review Early Access Care’s contributions to the Rare Disease Innovation Summit in Boston, focused on accelerating solutions for underserved patient populations.

Explore Early Access Care's insights from the 2018 ASCO Annual Meeting, highlighting expanded access and early clinical trial developments for patients in need.

See how Early Access Care is helping to bridge the gap between clinical research and real-world outcomes through innovative early access program strategies.

Get the full story on the Right to Try bill’s progress through Congress, and how legislative outcomes affect compassionate use pathways.

Explore Early Access Care’s expert insights into the Right to Try legislation and its implications for patient access and ethical clinical care.

Take a look back at Early Access Care’s year of impact, progress, and patient-focused initiatives in the field of expanded access to investigational therapies.

Understand the difference between real-world data and real-world evidence—and how both are vital in evaluating treatment outcomes through expanded access.

Understand the importance of regulatory and ethical compliance in expanded access programs, and how Early Access Care ensures responsible delivery.

Explore how FDA’s streamlined procedures are reducing barriers to expanded access, with insights from Early Access Care on implementation and impact.

Explore how SubHealth's review highlights Early Access Care’s role in enhancing patient access to investigational treatments through regulatory insight.

Read about the U.S. Senate’s approval of the Trickett Wendler Right to Try Act and Early Access Care’s perspective on its implications for patients.

Unpack the GAO’s findings on expanded access programs and how they align with Early Access Care’s mission to serve patients with critical unmet needs.

Highlights from the 2017 Expanded Access Summit in Cambridge, where Early Access Care shared strategies to improve patient access to investigational therapies.

Get highlights from Early Access Care’s participation in the Europe-based conference on early and managed access programs held in London.

Explore takeaways from the 2017 Educational Conference on Expanded Access, where Early Access Care shared strategies for ethical patient treatment pathways.

Learn how Early Access Care contributed to shaping clinical trial innovation at the NY Academy of Sciences, focusing on equitable access and patient-first solutions.

See how Early Access Care contributed expert insights on Cures regulation and expanded access during the DIA Annual Meeting in Chicago.

Discover how the Reagan-Udall Foundation’s Expanded Access Navigator improves transparency for patients, with support from Early Access Care.